Sanofi investigated by EU over alleged flu vaccine disparagement
Seeking Alpha ·
The European Commission has opened a formal antitrust investigation to assess whether Sanofi ( SNY ) has breached EU competition rules by carrying out a communication campaign that disparages the only rival flu vaccine recommended for vulnerable patients with risk factors.
DYAX Investor Sentiment
Bullish (Long) 27% · Bearish (Short) 73%
392 participants
Related News
- American Outdoor Brands gains after new products boost results
- Fortrea names Jason Knoblauch as CFO
- China Eastern Airlines to buy 25 Airbus A330 neo jets in $9.4B deal
- Meta and Snap Face Australia Youth Crackdown
- Is AI momentum starting to cool? BofA weighs in
- Beyond Air GAAP EPS of -$4.01 misses by $0.24, revenue of $7.7M misses by $0.38M